Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Fluorogenic Peptide Substrate for Quantification of Bacterial Enzyme Activities.

Al-Abdullah IH, Bagramyan K, Bilbao S, Qi M, Kalkum M.

Sci Rep. 2017 Mar 13;7:44321. doi: 10.1038/srep44321.

2.

Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation.

Balamurugan AN, Green ML, Breite AG, Loganathan G, Wilhelm JJ, Tweed B, Vargova L, Lockridge A, Kuriti M, Hughes MG, Williams SK, Hering BJ, Dwulet FE, McCarthy RC.

Transplant Direct. 2015 Dec 23;2(1):e54. doi: 10.1097/TXD.0000000000000563. eCollection 2016 Jan.

3.

A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells.

Volovitz I, Shapira N, Ezer H, Gafni A, Lustgarten M, Alter T, Ben-Horin I, Barzilai O, Shahar T, Kanner A, Fried I, Veshchev I, Grossman R, Ram Z.

BMC Neurosci. 2016 Jun 1;17(1):30. doi: 10.1186/s12868-016-0262-y.

4.

The Choice of Enzyme for Human Pancreas Digestion is a Critical Factor for Increasing the Success of Islet Isolation.

Qi M, Valiente L, McFadden B, Omori K, Bilbao S, Juan J, Rawson J, Scott S, Ferreri K, Mullen Y, El-Shahawy M, Dafoe D, Kandeel F, Al-Abdullah IH.

Transplant Direct. 2015 May;1(4). doi: 10.1097/TXD.0000000000000522.

5.

Different digestion enzymes used for human pancreatic islet isolation: a mixed treatment comparison (MTC) meta-analysis.

Rheinheimer J, Ziegelmann PK, Carlessi R, Reck LR, Bauer AC, Leitão CB, Crispim D.

Islets. 2014;6(4):e977118. doi: 10.4161/19382014.2014.977118. Epub 2014 Nov 7.

6.

Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Shapiro AM.

Rev Diabet Stud. 2012 Winter;9(4):385-406. doi: 10.1900/RDS.2012.9.385. Epub 2012 Dec 28. Review.

7.

Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal disease.

Benedict KA, Moassesfar S, Adi S, Gitelman SE, Brennan JL, McEnhill M, Stock PG, Portale AA, Posselt AM.

Am J Transplant. 2013 Aug;13(8):2207-10. doi: 10.1111/ajt.12323. Epub 2013 Jun 13.

8.

Clinical islet isolation outcomes with a highly purified neutral protease for pancreas dissociation.

O'Gorman D, Kin T, Pawlick R, Imes S, Senior PA, Shapiro AM.

Islets. 2013 May-Jun;5(3):111-5. doi: 10.4161/isl.25222. Epub 2013 Jun 11.

9.

Update on islet cell transplantation for type 1 diabetes.

Agarwal A, Brayman KL.

Semin Intervent Radiol. 2012 Jun;29(2):90-8. doi: 10.1055/s-0032-1312569.

10.

Update on islet transplantation.

McCall M, Shapiro AM.

Cold Spring Harb Perspect Med. 2012 Jul;2(7):a007823. doi: 10.1101/cshperspect.a007823. Review.

11.

A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products.

Balamurugan AN, Loganathan G, Bellin MD, Wilhelm JJ, Harmon J, Anazawa T, Soltani SM, Radosevich DM, Yuasa T, Tiwari M, Papas KK, McCarthy R, Sutherland DE, Hering BJ.

Transplantation. 2012 Apr 15;93(7):693-702. doi: 10.1097/TP.0b013e318247281b.

12.

Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.

Jahansouz C, Jahansouz C, Kumer SC, Brayman KL.

J Transplant. 2011;2011:247959. doi: 10.1155/2011/247959. Epub 2011 Oct 15.

13.

Tissue dissociation enzymes for isolating human islets for transplantation: factors to consider in setting enzyme acceptance criteria.

McCarthy RC, Breite AG, Green ML, Dwulet FE.

Transplantation. 2011 Jan 27;91(2):137-45. doi: 10.1097/TP.0b013e3181ffff7d. Review.

14.

Experience of islet isolation without neutral protease supplementation.

Kin T, O'Gorman D, Senior P, Shapiro AM.

Islets. 2010 Sep-Oct;2(5):278-82. Epub 2010 Sep 1.

15.

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.

Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG.

Transplantation. 2010 Dec 27;90(12):1595-601. doi: 10.1097/TP.0b013e3181fe1377.

16.

Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.

Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG.

Am J Transplant. 2010 Aug;10(8):1870-80. doi: 10.1111/j.1600-6143.2010.03073.x.

Supplemental Content

Support Center